Alexa Rupnik
Director, Oncology Hcp Strategy @ Merck
About Alexa Rupnik
Alexa Rupnik serves as the Director of Oncology HCP Strategy at Merck, a position she has held since 2022. With extensive experience in integrated pharmaceutical marketing, she has worked in various roles across multiple organizations, including Merck and Shire Pharmaceuticals.